Vinay Prasad, a top regulator at the US Food and Drug Administration, has left the agency after a controversy over his ...

Novo Nordisk tapped Maziar Mike Doustdar, its head of international operations, as its new chief executive officer and ...

US stocks gave up earlier gains on Tuesday as investors digested a wave of corporate earnings and economic data, while ...

US stocks pared earlier small gains on Tuesday, but kept a bid for more records in play as investors combed through a rush of corporate earnings and economic data key to the odds of interest-rate cuts ...

This regulatory relief, combined with several other compelling catalysts, creates a pathway for the stock to potentially ...

Sarepta Therapeutics shares snapped a three-day losing streak on Tuesday, as analysts said resumption of U.S. shipments for ...

It has been a tumultuous two weeks for Sarepta; however, the FDA reauthorising US shipments of Elevidys will be a welcome development.

After our editorial, the agency relents to allow a Duchenne treatment.

Knockoff copies of Novo’s weight loss medicine Wegovy have held back sales and put the drugmaker on the back foot in its ...

A former congressman will no longer seek an open U.S. Senate seat in North Carolina next year now that fellow Democrat Roy ...